Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
281
-
Total 13F shares, excl. options
-
94.7M
-
Shares change
-
-12.7M
-
Total reported value, excl. options
-
$1.59B
-
Value change
-
-$224M
-
Put/Call ratio
-
0.53
-
Number of buys
-
112
-
Number of sells
-
-135
-
Price
-
$16.83
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2021
353 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2021.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 281 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.7M shares
.
Largest 10 shareholders include ARK Investment Management LLC (15.5M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (9.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.39M shares), MACQUARIE GROUP LTD (4.74M shares), NORTHERN TRUST CORP (4.23M shares), Parametric Portfolio Associates LLC (3.77M shares), Mondrian Investment Partners LTD (3.7M shares), VANGUARD GROUP INC (2.5M shares), RENAISSANCE TECHNOLOGIES LLC (2.3M shares), and WELLS FARGO & COMPANY/MN (2.27M shares).
This table shows the top 281 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.